Dysregulated tsRNAs as Potential Biomarkers for Gastric Cancer
Author Information
Author(s): Yuan Jie, Gu Wenchao, Xu Tianxin, Zhang Yan, Shen Lei, Yan Jianliang, Guan Xi, Chu Haidan, Yuan Ruoyu, Ju Shaoqing
Primary Institution: Affiliated Hospital of Nantong University, Nantong University, Nantong, China
Hypothesis
Can transfer RNA-derived small RNAs (tsRNAs) serve as effective biomarkers for early diagnosis of gastric cancer?
Conclusion
Dysregulated tsRNAs in gastric cancer patients' serum show significant potential as new biomarkers for early diagnosis.
Supporting Evidence
- Three up-regulated tsRNAs were significantly elevated in gastric cancer patients compared to healthy controls.
- ROC analysis showed that the diagnostic efficacy of tsRNAs was superior to traditional biomarkers like CEA and CA199.
- High-throughput sequencing identified 435 dysregulated tsRNAs in gastric cancer tissues.
Takeaway
Scientists found that tiny pieces of RNA in the blood can help doctors find stomach cancer early, which is really important for treatment.
Methodology
High-throughput sequencing was used to identify differentially expressed tsRNAs, followed by validation using qRT-PCR on serum and tissue samples.
Limitations
The study had a limited sample size and the clinical application of these biomarkers is not yet established.
Participant Demographics
60 gastric cancer patients and 60 healthy controls.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI, 0.694–0.924
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website